JPMorgan Chase, Wells Fargo and BlackRock reported strong quarterly results to kick off earnings season, but concerns linger ...

Jeffrey Smith, who runs Starboard, pushed Pfizer's board on Thursday to set up a special committee to probe potential ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...

The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

There was some intriguing news from a Pfizer (NYSE: PFE) shareholder on Thursday that was not taken well by the market.

Former Pfizer CEO Ian Read and former CFO Frank D’Amelio announced their withdrawal from Starboard Value’s activist campaign ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Hedge fund Starboard Value's activist campaign targeting Pfizer (PFE) divides Wall Street, with analysts questioning the ...

Two former Pfizer executives published a statement saying they support the current company management as it gets pressured ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current CEO ...

Two former Pfizer top executives won’t participate in an activist investor’s effort to pressure the drugmaker to make changes ...